A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer

出版年份 2018 全文链接

标题

作者

关键词

gene therapy, cell cycle control, 10-year cancer-free survivor, pancreas adenocarcinoma, cyclin G1 inhibitor, retrovector, tumor targeting, targeted gene delivery, CCNG1

出版物

Molecular Therapy-Oncolytics

Volume 12, Issue -, Pages 56-67

出版商

Elsevier BV

发表日期

2018-12-14

DOI

10.1016/j.omto.2018.12.005

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation